Eagle Health Investments LP - Q3 2023 holdings

$454 Million is the total value of Eagle Health Investments LP's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
ICLR  ICON PLC$45,851,750
-1.6%
186,2000.0%10.10%
+16.0%
UTHR  UNITED THERAPEUTICS CORP DEL$38,587,179
+2.3%
170,8380.0%8.50%
+20.6%
ARGX  ARGENX SEsponsored adr$31,660,972
+26.1%
64,4000.0%6.98%
+48.6%
NTRA  NATERA INC$26,359,460
-9.1%
595,6940.0%5.81%
+7.2%
ALNY  ALNYLAM PHARMACEUTICALS INC$24,219,488
-6.8%
136,7560.0%5.34%
+9.9%
 PROCEPT BIOROBOTICS CORP$11,064,123
-7.2%
337,2180.0%2.44%
+9.4%
AGIO  AGIOS PHARMACEUTICALS INC$6,623,843
-12.6%
267,6300.0%1.46%
+3.0%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$6,620,987
-18.8%
1,214,8600.0%1.46%
-4.3%
FDMT  4D MOLECULAR THERAPEUTICS IN$5,574,607
-29.6%
437,9110.0%1.23%
-17.0%
PNT  POINT BIOPHARMA GLOBAL INC$2,041,967
-26.4%
306,1420.0%0.45%
-13.3%
CMAX  CAREMAX INC$1,515,281
-31.8%
714,7550.0%0.33%
-19.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings